LQDA
Price:
$9.095
Market Cap:
$698.44M
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.[Read more]
Industry
Biotechnology
IPO Date
2018-07-26
Stock Exchange
NASDAQ
Ticker
LQDA
According to Liquidia Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -5.68. This represents a change of -21.06% compared to the average of -7.20 of the last 4 quarters.
The mean historical PE Ratio of Liquidia Corporation over the last ten years is -5.17. The current -5.68 PE Ratio has changed 10.88% with respect to the historical average. Over the past ten years (40 quarters), LQDA's PE Ratio was at its highest in in the December 2017 quarter at 2.90. The PE Ratio was at its lowest in in the December 2022 quarter at -17.22.
Average
-5.17
Median
-3.41
Minimum
-10.12
Maximum
-1.70
Discovering the peaks and valleys of Liquidia Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.16%
Maximum Annual PE Ratio = -1.70
Minimum Annual Increase = -41.67%
Minimum Annual PE Ratio = -10.12
Year | PE Ratio | Change |
---|---|---|
2023 | -9.96 | -1.60% |
2022 | -10.12 | 24.60% |
2021 | -8.12 | 367.16% |
2020 | -1.74 | 2.09% |
2019 | -1.70 | -41.67% |
2018 | -2.92 | -10.68% |
2017 | -3.27 | -7.76% |
The current PE Ratio of Liquidia Corporation (LQDA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-9.40
5-year avg
-6.33
10-year avg
-5.17
Liquidia Corporation’s PE Ratio is less than BioMarin Pharmaceutical Inc. (62.30), greater than Vaxcyte, Inc. (-26.31), greater than Legend Biotech Corporation (-30.94), less than Bio-Techne Corporation (67.14), less than United Therapeutics Corporation (14.35), greater than Geron Corporation (-12.66), less than NRx Pharmaceuticals, Inc. (-0.69), less than Agenus Inc. (-0.47), less than Replimune Group, Inc. (-3.26), less than Nuvectis Pharma, Inc. (-4.95), less than Lyra Therapeutics, Inc. (-0.18), less than Kronos Bio, Inc. (-0.58), less than Gossamer Bio, Inc. (-2.55), greater than Terns Pharmaceuticals, Inc. (-6.06), less than Amylyx Pharmaceuticals, Inc. (-0.97), less than Acumen Pharmaceuticals, Inc. (-2.06), less than Inozyme Pharma, Inc. (-3.48), less than X4 Pharmaceuticals, Inc. (7.41), greater than Immunocore Holdings plc (-27.58), greater than Mirum Pharmaceuticals, Inc. (-18.21), greater than Larimar Therapeutics, Inc. (-8.80), less than KalVista Pharmaceuticals, Inc. (-4.02),
Company | PE Ratio | Market cap |
---|---|---|
62.30 | $16.01B | |
-26.31 | $12.45B | |
-30.94 | $9.90B | |
67.14 | $11.34B | |
14.35 | $15.38B | |
-12.66 | $2.56B | |
-0.69 | $17.52M | |
-0.47 | $106.78M | |
-3.26 | $708.49M | |
-4.95 | $115.27M | |
-0.18 | $17.85M | |
-0.58 | $59.36M | |
-2.55 | $205.87M | |
-6.06 | $549.60M | |
-0.97 | $161.36M | |
-2.06 | $133.38M | |
-3.48 | $312.42M | |
7.41 | $109.78M | |
-27.58 | $1.67B | |
-18.21 | $1.96B | |
-8.80 | $513.64M | |
-4.02 | $531.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liquidia Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Liquidia Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Liquidia Corporation's PE Ratio?
How is the PE Ratio calculated for Liquidia Corporation (LQDA)?
What is the highest PE Ratio for Liquidia Corporation (LQDA)?
What is the 3-year average PE Ratio for Liquidia Corporation (LQDA)?
What is the 5-year average PE Ratio for Liquidia Corporation (LQDA)?
How does the current PE Ratio for Liquidia Corporation (LQDA) compare to its historical average?